Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  4,353 results for ""Aryl Hydrocarbon Hydroxylases genetics""

Your Filters

Filter by : Subject Phrase Sort Order : Relevance
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Identification of New Substrates and Inhibitors of Human CYP2A7.

  • Authors : Ashraf RA; School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin 300072, China.; Liu S

Subjects: Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/genetics ; Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/metabolism ; Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/antagonists & inhibitors

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 May 08; Vol. 29 (10). Date of Electronic Publication: 2024 May 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

Read More Add to Saved list
×
Academic Journal

Association between gene polymorphisms and initial warfarin therapy in patients after heart valve surgery.

  • Authors : Liu Z; Department of Laboratory Medicine, State Key Laboratory of Cardiovascular Disease, Beijing Key Laboratory for Molecular Diagnostics of Cardiovascular Diseases, Center of Laboratory Medicine, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Luo F

Subjects: Warfarin*/Warfarin*/Warfarin*/therapeutic use ; Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/genetics; Humans

  • Source: Pharmacological reports : PR [Pharmacol Rep] 2024 Apr; Vol. 76 (2), pp. 390-399. Date of Electronic Publication: 2024 Mar 08.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101234999 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Influence of novel CYP2C-haplotype on proton pump inhibitor pharmacokinetics in children.

  • Authors : Kyler KE; Division of Hospital Medicine, Children's Mercy Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.

Subjects: Proton Pump Inhibitors*/Proton Pump Inhibitors*/Proton Pump Inhibitors*/pharmacokinetics ; Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/genetics ; Cytochrome P-450 Enzyme System*

  • Source: Clinical and translational science [Clin Transl Sci] 2024 Apr; Vol. 17 (4), pp. e13782.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical application of a real-time polymerase chain reaction test for CYP2C19 genotyping based on genotype distribution in a healthy Korean population.

  • Authors : Park K; Department of Laboratory Medicine, Sanggye Paik Hospital, School of Medicine, Inje University, Seoul, Republic of Korea.; Yoo SJ

Subjects: Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/genetics; Humans ; Genotype

  • Source: Laboratory medicine [Lab Med] 2024 Mar 07; Vol. 55 (2), pp. 234-237.Publisher: Oxford University Press Country of Publication: England NLM ID: 0250641 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Response to "What is the Current Clinical Impact of the CYP2C:TG Haplotype?"

  • Authors : Zubiaur P; Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain.; Leeder JS

Subjects: Cytochrome P-450 Enzyme System*/Cytochrome P-450 Enzyme System*/Cytochrome P-450 Enzyme System*/genetics ; Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/genetics; Humans

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Feb; Vol. 115 (2), pp. 184. Date of Electronic Publication: 2023 Nov 16.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Read More Add to Saved list
×
Academic Journal

Association Study of Esomeprazole Pharmacokinetics and CYP2C19 Gene Polymorphisms.

  • Authors : Fang Y; Department of Gastroenterology, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.; Department of Clinical Research Management, West China Hospital, Sichuan University, Wuhou, Chengdu, P.R. China.

Subjects: Esomeprazole* ; Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/genetics ; Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/metabolism

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Feb; Vol. 13 (2), pp. 134-139. Date of Electronic Publication: 2023 Sep 29.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati population.

  • Authors : Khasawneh LQ; Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box: 15551, Al-Ain, United Arab Emirates.; Alsafar H

Subjects: Platelet Aggregation Inhibitors*/Platelet Aggregation Inhibitors*/Platelet Aggregation Inhibitors*/therapeutic use ; Platelet Aggregation Inhibitors*/Platelet Aggregation Inhibitors*/Platelet Aggregation Inhibitors*/pharmacology ; Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/genetics

  • Source: Human genomics [Hum Genomics] 2024 Jan 03; Vol. 18 (1), pp. 2. Date of Electronic Publication: 2024 Jan 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101202210 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-7364

Record details

Read More Add to Saved list
×
Academic Journal

Acute kidney injury interacts with VKORC1 genotype on initiative warfarin dose among heart surgery recipients: a real-world research.

  • Authors : Xiong L; Department of Pharmacy, Nanjing Drum Tower Hospital, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.; Yu F

Subjects: Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/genetics ; Cardiac Surgical Procedures*/Cardiac Surgical Procedures*/Cardiac Surgical Procedures*/adverse effects ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/genetics

  • Source: Scientific reports [Sci Rep] 2023 Dec 08; Vol. 13 (1), pp. 21750. Date of Electronic Publication: 2023 Dec 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Development of an electrochemical DNA-based biosensor for the detection of the cardiovascular pharmacogenetic-altering SNP CYP2C9*3.

  • Authors : Morais SL; REQUIMTE/LAQV, ISEP, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida, 4249-015, Porto, Portugal.; Magalhães JMCS

Subjects: Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/Aryl Hydrocarbon Hydroxylases*/genetics ; Biosensing Techniques*; Humans

  • Source: Talanta [Talanta] 2023 Nov 01; Vol. 264, pp. 124692. Date of Electronic Publication: 2023 Jun 01.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 2984816R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CYP2C19 loss-of-function alleles are not associated with higher prevalence of gastrointestinal bleeds in those who have been prescribed antidepressants: Analysis in a British-South Asian cohort.

Subjects: Antidepressive Agents*/Antidepressive Agents*/Antidepressive Agents*/adverse effects ; Antidepressive Agents*/Antidepressive Agents*/Antidepressive Agents*/metabolism ; Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/genetics

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Nov; Vol. 89 (11), pp. 3432-3438. Date of Electronic Publication: 2023 Aug 06.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  4,353 results for ""Aryl Hydrocarbon Hydroxylases genetics""